why has my weight loss stalled on tirzepatide plateauing Hit a plateau? You're not alone. Here's some ways to What To Do When You

But its thought that it has to do with how these drugs affect the autonomic nervous system, which is in control of the digestive tracts bodily functions

Clin Res

Dual GIP/GLP-1 agonists now represent the highest-revenue growth segment in the GLP-1 weight loss drug market at 18.4% CAGR , with tirzepatide generating USD 18.3 billion in 2025 revenue through Zepbound and Mounjaro surpassing Eli Lillys entire insulin franchise within two years of commercial launch

FDA-approved anti-obesity drugs in the United States

I would say consult somebody who has expertise in treatment of obesity, which may or may not be your primary care physician